Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2013: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Research Abstract |
High density lipoprotein (HDL) stimulated AMP kinase (AMPK) in human umbilical vein endothelial cells (HUVECs). HDL activated AMPK through independent two pathways. HDL-induced AMPK activation was mediated by sphingosine-1 phosphate (S1P)/S1P receptor pathway and scavenger receptor (SR-BI)/PDZK-1. S1P/S1P receptor pathway was mediated by calmodulin. SR-BI/PDZK-1 pathway was mediated by calmodulin and LKB1 in HUVECs. Simvastatin, fenofibrate, metrformin and AICAR enhanced protein expression of SR-BI and endothelial nitric oxide synthase (eNOS) in HUVECs. Simultaneous pretreatment of simvastatin and fenofibrate enhanced HDL-induced AMPK/Akt activation in HUVECs.
|